Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

The Top Five (Non-COVID) Pharma Stories Of 2021

Jan 11 2022

• By Kevin Grogan

Stone — 2021 was a tough year for biopharma • Source: Alamy

Related Content

Cerevel Makes Progress, But Karuna Still One To Watch In Schizophrenia

Jul 06 2021

Bayer Ponders Road Less Traveled And Trip Savings In Pandemic

Feb 26 2021

Finance Watch: Ten IPOs In Three Days Raise $1.9bn

Feb 08 2021

Biogen/Eisai Win On Aduhelm Approval Bet And Wager Next On Price

Jun 07 2021

Cautious Optimism For Alzheimer's Mounts Among Industry R&D Leaders

Aug 11 2021

Astellas Pauses XLMTM Gene Therapy Trial After Another Safety Scare

Sep 01 2021

Shortsellers Say Gingko BioWorks Is ‘Colossal Synthetic Biology Scam'

Oct 07 2021

Lilly Targets Aduhelm With Aggressive Plans For Donanemab In Alzheimer’s

Oct 26 2021

Merck Extends Timeline On Acceleron Deal, Still Expects Q4 Close

Nov 01 2021

Novartis Sneaks Ahead Of Sanofi To Buy Gyroscope

Dec 22 2021

$1bn Amunix Buy Brings Sanofi Next-Generation TCE Platform

Dec 21 2021

SPAC Mergers Take Biopharmas Public, But Valuations Often Sag Post-Closing

Dec 22 2021

Biogen Halves Aduhelm Price, Readies $500m In Cost Cuts

Dec 20 2021

Novartis Plumps For Share Buybacks Before Bolt-On M&A

Dec 16 2021

Fundraising Tips From The Top Of European Biotech

Jul 12 2021

Bayer Bids To Be A Winner In Cell & Gene Therapy

Dec 08 2020

Artios On How To Strike A Deal With Big Pharma

Apr 14 2021

Pandemic Perspectives: What’s The New Normal For The Business Of Biopharma?

Mar 18 2021

After Setbacks, Confidence Grows In Likely Success For Sarepta’s Duchenne Gene Therapy

Jan 11 2022

EY: Don’t Expect Mega-Mergers To Return, But ‘Never Say Never’

Jan 10 2022

Related Companies

Sanofi

Translate Bio

Kadmon Holdings, Inc.

ORIGIMM Biotechnology

Amunix Pharmaceuticals, Inc.

Merck & Co., Inc.

Acceleron Pharma, Inc.

Jazz Pharmaceuticals plc

GW Pharmaceuticals plc

Johnson & Johnson

Pfizer Inc.

Novartis AG

Sana Biotechnology, Inc.

Cerevel Therapeutics Holdings, Inc.

Gelesis, Inc.

Nautilus Biotechnology Inc.

Biogen, Inc.

Eisai Co., Ltd.

Roche Holding AG

Eli Lilly and Company

Bayer AG

Asklepios BioPharmaceutical, Inc.

BlueRock Therapeutics LP

Gyroscope Therapeutics Limited

Genetix Biotherapeutics

Astellas Pharma, Inc.

Sarepta Therapeutics, Inc.

Additional Topics

Gene Therapy M & A Commercial Business Strategies Scrip Perspectives BioPharmaceutical

More from Scrip Perspectives

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window